$96.1 Million is the total value of Stonepine Capital Management, LLC's 17 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BBI | Exit | BRICKELL BIOTECH INC | $0 | – | -146,739 | -100.0% | -0.28% | – |
| CERC | Exit | CERECOR INC | $0 | – | -450,500 | -100.0% | -2.27% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CTI Biopharmap Corp. | 24 | Q1 2023 | 14.8% |
| APOLLO ENDOSURGERY INC | 23 | Q1 2023 | 15.6% |
| XOMA CORP | 23 | Q2 2024 | 5.7% |
| Cumberland Pharmaceuticals, Inc. | 19 | Q4 2020 | 7.0% |
| Amarin Corp PLC - SPONS ADR | 14 | Q3 2022 | 23.2% |
| VANDA PHARMACEUTICALS INC | 14 | Q3 2023 | 20.9% |
| EVOLUS INC | 14 | Q2 2024 | 29.7% |
| BIODELIVERY SCIENCES INTL | 14 | Q1 2020 | 12.9% |
| EXAGEN INC | 14 | Q2 2024 | 4.6% |
| ADMA BIOLOGICS INC | 13 | Q2 2024 | 19.2% |
View Stonepine Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Surrozen, Inc./DE | April 19, 2024 | 199,158 | 6.0% |
| ALIMERA SCIENCES INC | February 13, 2024 | 5,373,732 | 10.0% |
| aTYR PHARMA INC | February 13, 2024 | 482,258 | 0.8% |
| AYTU BIOPHARMA, INC | February 13, 2024 | 565,484 | 10.0% |
| DELCATH SYSTEMS, INC. | February 13, 2024 | 208,333 | 0.9% |
| Evolus, Inc. | February 13, 2024 | 5,333,004 | 9.3% |
| EXAGEN INC. | February 13, 2024 | 669,684 | 3.9% |
| Gamida Cell Ltd. | February 13, 2024 | 3,000,000 | 2.2% |
| IO Biotech, Inc. | February 13, 2024 | 3,641,345 | 5.4% |
| Rezolute, Inc. | February 13, 2024 | 2,768,656 | 7.0% |
View Stonepine Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-26 |
| 13F-HR/A | 2024-08-21 |
| SC 13G | 2024-08-15 |
| 13F-HR | 2024-08-13 |
| SC 13G | 2024-07-29 |
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-04-19 |
| 13F-HR | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
View Stonepine Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.